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Abstract Genetic screening in the primary care setting is the future of preventative medi-
cine. Genetic testing is an important medical tool for assessing various inheritable diseases,
conditions, and cancers. The ability to diagnose patients before symptoms surface can help
lessen the severity of symptoms and promote quality of life. However, genetic screening can
cause psychological distress from the knowledge of test results, in some cases only serving
to increase the risk of developing a condition due to stress. Genetic testing can be conducted
anytime in life, even before birth. In this review, a compilation of genetic testing’s definitions
and boundaries, factors influencing an individual’s test outcomes, and an overview of a wide
variety of diseases, conditions and cancers were collected.
Copyright ª 2018, Chongqing Medical University. Production and hosting by Elsevier B.V. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
Introduction
In the world of modern health care, innovation leads the
way to not only better patient care, but also a deeper un-
derstanding of preventative medicine. The ability to treat a
genetic disease before it may become severe is a scientific
feat that, until recent years, has been unknown to physi-
cians. Genetic testing saves countless lives that would
otherwise fall prey to congenital diseases (i.e. Tay Sachs
and Cystic Fibrosis) and cancers (i.e. breast and colon).1e3
By understanding at a genetic level how a patient may be
predisposed to certain health conditions, the planning for
their care can start before an unfavorable prognosis, and
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not hastily chasing after one.4 Primary care physicians
possessing the advantage of an early start on planned
treatment gives us the ability to elude health issues that
may later consume a patient’s life. As a result, this surge in
genetic screening in primary care physician offices can
change lives.2
Unfortunately, for many diseases today genetic analysis
will not be able to cure the patient completely ahead of the
racing clock. However, it may have the ability to soften the
blow of a debilitating disease by lessening the severity of
symptoms or preventing it from manifesting early in life.4 A
physician’s mission to care, cure, and comfort is enhanced
with genetic screening. The faculty to understand and treat
preventively can massively enhance the quality of life for a
patient. In short, genetic testing in a primary care setting
can transform otherwise sick lives into healthier, or even
healthy lives.4
Genetic disorders
Genetic testing works by analyzing changes in DNA that have
been linked to certain diseases, conditions and cancers.5e8
There are over 7000 disorders that are believed to be
linked to Mendelian genetics, and over 700 tests available
currently.9 Analyzing these changes through genetic testing
is most useful when an individual has had family members
affected by the condition, or if the disease could be linked to
inheritance through the process of Mendelian genetics.10,11
By seeing patterns of diagnosis in relatives, primary care
physicians can use those past cases to recommend specific
genetic tests to their patients.5 Different diseases can be
inherited in a variety of ways depending on themagnitude of
influence the gene (or genes) being investigated may have.4
If it is recessive or dominant, or if the severity is dependent
on being heterozygous or homozygous in nature, this may
also impact the severity of the condition.6,12,13 More often
than not, the severity of a disease or the probability of
manifesting a disease’s detrimental symptoms is increased
when familial cases are common.4 Genetic testing can also
identify those that have a higher chance of showing symp-
toms of the condition or those that are at risk of passing it on
if they have progeny.6,7,10,12,14 This allows for primary care
physicians to collect patient data for future generations,
aiding in the tracking and prediction of future diagnoses.15
Various unavoidable genetic diseases that impact an
individual from birth are critical to identify early in a pa-
tient’s life. This is in order to make informed decisions
about choices of planned care to improve quality of
life.6,7,12 Inherited genetic diseases of a recessive nature
have been shown to account for nearly 20% of total infant
mortality and 10% of infant hospitalization in the United
States.12 Other conditions, such as congenital deafness, can
also be linked to hereditary causes.7
Down syndrome
The age of a mother has also been shown to have a negative
impact on the occurrence of genetic diseases such as Down
syndrome, with higher incidence development of negative
reactions to drugs found in women who give birth older
than 35 years of age.16 Due to rising popularity in screening,
older mothers can obtain a better understanding of how
probable passing on a hereditary condition such as Down
syndrome would be.16,17 Screening for theses genetic dis-
eases from preconception has been shown to greatly reduce
these statistics and reduce mortality in infant cases stem-
ming from these genetic conditions.12,13
Cystic Fibrosis, Tay Sachs, familial dysautonomia,
and BRCA genes
Multiple factors influence whether an individual will be
tested, two of which include considerations such as family
history and ethnicity.14 As stated before, genetic testing is
best utilized when closely related individuals to the patient
have tested positive for the mutation or have the condi-
tion.10,14 Certain ethnicities are more likely to carry certain
genes. For example, due to the knowledge obtained from
genetic screening, individuals of Ashkenazi Jewish descent
have a higher percentage of particular genetic disorders
including as Cystic Fibrosis, Tay Sachs, familial dysautono-
mia, and the development of BRCA genes.1,6,11,14,16 Thus, as
part of primary care a physician may recommend screening
due to a patient’s background.4 This enables the physician to
preventatively identify conditions before they may have the
ability to become debilitating. Genetic screening has seen a
surge in popularity among demographics such as individuals
of Ashkenazi Jewish descent, and this increase in screening
has shown to decrease the number of Tay Sachs cases in said
population.11,14 With genetics becoming underlined as a
point of study in modern primary care, other diseases could
see similar patterns.11,18 This would result in early diagnosis,
as well as the disease prevalence in its respective population
decreasing in a similar fashion to Tay Sachs. This means that
looking forward, genetic testing can be applied to any dis-
ease’s preventative treatment so long as the disease has
proven to be hereditary.
Tay Sachs in the Ashkenazi Jewish population has greatly
diminished from testing as well.1,6 Early diagnosis of con-
ditions such as Tay Sachs has been proven to favorably
impact the survival and quality of life for those patients.8,19
Cancer
Colorectal cancer
One of the more understood hereditary cancers is colo-
rectal cancer.20 Several diversified genes have been linked
to different cancers of the colon such as familial adeno-
matous polyposis (FAP), hereditary nonpolyposis colorectal
cancer (HNPCC), and Turcot’s syndrome which has been
linked to the same genes being altered from FAP and
HNPCC.21 Mutations, or altering of the gene(s) involved,
occurs in the germ lining which can subsequently lead to
the development of cancer.3,8,14,21 Testing positive for FAP,
HNPCC or Turcot’s syndrome does not guarantee an indi-
vidual will develop cancer.20 However, it does mean that an
individual will have an increased likelihood of developing
cancer and are without a doubt carrying the gene for its
existence.21 Thus, they have the ability to pass it on.21 As
with many cancers, testing positive for these different gene
mutations increases the chance of developing the cancer.20
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Nonetheless it should be said that environmental and
lifestyle factors (i.e. diet and exercise) have the potential
to largely influence the development of the colorectal
cancer.3,20 External factors of an individual’s life can also
negatively or positively influence other mutations to genes
that are not testable at this time with modern tech-
niques.14 The colorectal cancers are autosomal dominant in
inheritance; meaning that if one of the parents is a carrier,
the offspring has a 50% chance of inheriting the mutated
gene that is predisposed for the development of cancerous
polyps.14 Genetic screening will enable possible parents
to take their inherited high probability of developing
colorectal cancer into account when and if deciding to have
children.3,20
Breast and ovarian cancer
Breast and ovarian cancer can also be hereditary with
approximately 5e10% of all patients diagnosed having a
genetic link to the autosomal dominant mutation of the
BRCA1 or BRCA2 genes.22 As stated before with the colo-
rectal cancers, the presence of BRCA1 or BRCA2 genes
means that an individual has a higher predisposition to
developing cancer than someone without the gene pre-
sent.19 The gene is inherited in an autosomal dominant
fashion, and thus can affect both men and women.22 When
at least one of these mutations is present, it is more likely
that the cancer develops in an individual at a younger age
and tumors will be identified bilaterally in the body.14
Overall, the mutation of these genes are rare: estimated
at 1 in 500 or 1 in 833.14 These mutations in the BRCA genes
are 10 times more common in those of Ashkenazi Jewish
descent.14
Genetic testing is important for identifying those at
higher risk of cancer but can also be used for identifying
cases where prevention and treatment are useful for un-
derstanding underlying genetics.8,19 In both breast/ovarian
cancer and colorectal cancer, the predictive test for the
respective gene mutations for each cancer aids in raising
awareness of symptoms as they present, so treatment may
be done in a timely matter.3,8 There is also data that exists
suggesting that chemoprevention can help reduce the risk
of breast cancer with those who have tested positive for
only one of the BRCA genes.23 Testing positive for the gene
has also shown to have a positive impact on individuals
because it allows them to live a healthier lifestyle by being
more aware of their bodily health.8
Neurological disorders
Alzheimer’s disease
Some genetic diseases are more likely to affect individuals
later on in life, such as the cancer, Alzheimer’s, and Hun-
tington’s disease.3,5 Many diseases that are linked to ge-
netic inheritance have tests still in development.13
Alzheimer’s disease has been shown to have genetic in-
heritance, however the genetic testing may not be as useful
as other tests.24 This is solely because there is no stopping
or preventing the disease progression in a method that
exists yet in modern medical science. Because of this, a
potential patient may not want to spend time and money on
a genetic test for Alzheimer’s when getting early treatment
will do nothing to heighten quality of life with the disease
as it progresses.24,25 To add, the information given very
early to a patient about the existence of the disease may be
worse in the long run due to psychological impacts and
long-term heightened stress.19,24,25
Huntington’s disease
Genetic screenings play an integral role in preconception
planning as symptoms may not have evolved to prominence
yet in newborns, but have the capacity to subsequently be
expressed during their lives.2,8,14 For Huntington’s disease,
symptoms do not usually display themselves until after the
point of reproductive maturity at which point an individual
tries to have a child. This leads to higher chances of
the autosomal dominant gene being passed on. Screening
for Huntington’s can be done at any time, pre-or post-natal
which makes it easily operative to those susceptible.23,26
Cardiovascular disorders
Cardiovascular diseases have many different components
but some have multigenic or monogenic causes which can
be tested for. One monogenic cause that can lead to early
cardiovascular disease is familial hypercholesterolemia.
With cardiovascular disease, there are often many
factors to consider and thus genetic testing can only show
a predisposition.25 Other diseases such as hypertension,
hemochromatosis, polycystic kidney disease, and dia-
betes that have been linked to genetics also have existing
tests.5,27
Blood disorders
Beta thalassaemia
Genetic testing is useful in countless ways: from being a
preventative method with cancer to reducing the preva-
lence of genetically predictable conditions overall.6,28 Beta
thalassaemia has had an 80e100% decrease in new births
in Mediterranean countries where prenatal and postnatal
genetic testing was implemented in the primary care
environment.28
Sickle cell anemia
Diseases can vary in severity depending on how the
symptoms manifest and by which route the condition was
inherited.13 For example, sickle cell anemia is an inherited
autosomal recessive disease. However, in its heterozygous
state it is survivable with symptoms ranging from rare to
none if the person is a carrier. Having genetic testing
conducted allows a better chance for autosomal recessive
survival, because treatment can start quickly and lead to
an improved prognosis.28 It also enables carriers to be
aware of their unseen genetic mutation and take that into
account if in the future they would want to conceive a
child.
The importance of preventative medicine 3
+ MODEL
Please cite this article in press as: Sandler S, et al., The importance of preventative medicine in conjunction with modern day genetic
studies, Genes & Diseases (2018), https://doi.org/10.1016/j.gendis.2018.04.002
Endocrine disorders
Examples of preventative measures after diagnosis via
preventive genetic testing in multiple endocrine neoplasia
type 2 has been shown.19 Those that are carriers have
benefited from preventative measures such as thyroidec-
tomy which greatly reduces the chance of dying from thy-
roid cancer or an inherited disorder of the thyroid gland.19
Treatment effects
A new future in curing diseases via pharmaceuticals and
other treatments, even if they are unrelated to hereditary,
can be paved due to genetic testing for familial diseases.13
As discussed before, certain ethnicities have various
genetic patterns that can increase their likelihood of
developing diseases, however these genetic patterns can
also lead to development of negative reactions to drugs.14
Response from drugs and varying levels of toxicity could
have a large impact on the body due to an individual’s
genetics and certain genes.13
Genetic testing methods
Genetic testing can be accomplished through several
different methods. Blood, saliva and amniotic fluid can be
tested to find abnormal genomic sequences that may lead
to familial conditions.8,14,29 These bodily fluids are easily
accessible by primary care physicians, and are thus samples
that can be optimally collected in that setting.4,15 Testing
can also be conducted at practically any stage during a pa-
tient’s life.11 Individuals who know they are or can become
carriers, and are seeking to have a child, may wish to have
preconception genetic testing done to ensure their child will
not be affected.11 Testing can occur before a baby is born in
the prenatal environment of the mother’s womb via amnio-
centesis.29 Testing can also be executed postnatally any time
after birth.15 More often than not, patients choose to have a
genetic test conducted either when symptoms arise or as a
preventative measure in patients with a family history of
the condition.11,23 The ease of collecting sample genetic
material from a patient, as well as the flexibility of testing a
patient anytime throughout their life are both positive
attributes to introducing genetic testing in the primary care
physician setting more throughout the coming decades.
Testing can also be performed in hospitals. Genetic
counselors in the hospital setting may recommend
screening when a patient is administered due to symptoms
noticed or analyzing patterns in a patient’s family medical
history.4 Additionally, genetic testing is being introduced in
the more informal setting via a primary care physician.7,18
The introduction of genetic testing and screening pro-
grams into primary care is becoming paramount as it in-
creases opportunities for people to become tested.2 The
more opportunities for easy and unintimidating genetic
testing, the more people will be in charge of their medical
future and plan of care. As a result, the people tested ac-
quire a deeper understanding of genetics which can lead to
quicker and more efficient treatment that ultimately leads
to decreased mortality.10,19
Factors influencing genetic screening
participation
There are some individuals who would prefer not to know
if a familial affliction has been passed on to them for psy-
chological reasons (i.e. trauma over realization of an
inherited fatal disease). However, many individuals would
like to know if a mutation is present within their genome to
prepare for treatment and understand the potential the
disease may influence on their future.23,24 Many different
factors play into getting tested such as financial security
in order to pay for the test, psychological reasons as
mentioned previously for reacting to austere results
(including family members who may become alerted as well
to the possibility of their own genetic mutations), and in-
surance companies reacting to the results and how their
control may hike medical costs drastically for a patient.23,26
All of these factors can impact an individual’s decision to
get tested or not.26
Conclusion
Genetic testing is a valuable source of a patient’s medical
wellbeing. If wielded productively, it can provide vital data
to help predict hereditary disease contraction as well as
provide time to plan for care if a detrimental genetic
disease such as Tay Sachs, Alzheimer’s disease, or Down
syndrome, is confirmed.1,15,23 In recent years the intro-
duction of genetic screening via primary care physicians has
ultimately lead to the prevention of and heightened quality
of treatment for several familial diseases in countless
cases.2,12 In the years to come genetic tests will become
increasingly more accessible in familiar outlets for efficient
family health care, especially in the primary care setting.
Only time will reveal how DNA tests will evolve to reach
more people, utilizing cutting edge scientific research as its
cornerstones to propel itself to new heights.
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